RF – An Update on the Pharmacologic Management of Androgenetic Alopecia in Transgender Patients
February 2025
in “
Actas Dermo-Sifiliográficas
”
TLDR Transgender patients with hair loss need personalized treatment plans considering their unique needs.
The article provides an update on the pharmacologic management of androgenetic alopecia in transgender patients, focusing on the unique considerations required for this population. It discusses the effectiveness and safety of various treatments, including hormone therapy and other medications, in addressing hair loss while considering the hormonal needs and transitions of transgender individuals. The review emphasizes the importance of personalized treatment plans that account for the specific medical and psychological needs of transgender patients experiencing androgenetic alopecia.